Ovid Therapeutics Inc. (OVID) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 120.19M |
| Enterprise Value | 120.46M |
| P/E Ratio | -6.78 |
| PEG Ratio | 0.23 |
| Price/Sales Ratio | 374.18 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 373.17 |
| Enterprise/EBITDA | -11.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -29.71 |
| Operating Margin | -47 |
| Return On Assets | -0.19 |
| Return On Equity | -0.23 |
| Revenue | 7.25M |
| Revenue/Share | 0.01 |
| Gross Profit | 6.95M |
| EBITDA | -17.14M |
| Net Income | -17.41M |
| Diluted EPS | -0.24 |
| Total Cash | 136.6M |
| Total Cash/Share | 0.67 |
| Total Debt | 12.35M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 11.97 |
| Book Value Per Share | 0.98 |
| 52-Week Change | 105.93 |
| 52-Week High | 3.11 |
| 52-Week Low | 1.18 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 2.4 |
| Average Volume | 1.88M |
| Shares Outstanding | 195.3M |
| % Held by Institutions | 199.97 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |